PPP6C
Basic information
Region (hg38): 9:125146573-125189939
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPP6C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 4 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 6 | 0 | 1 |
Variants in PPP6C
This is a list of pathogenic ClinVar variants found in the PPP6C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-125149695-G-A | not specified | Uncertain significance (Aug 26, 2024) | ||
9-125149801-G-A | Malignant melanoma of skin • Squamous cell lung carcinoma | Likely pathogenic (May 31, 2016) | ||
9-125149898-T-A | not specified | Uncertain significance (Oct 08, 2024) | ||
9-125153593-A-G | Benign (Jul 06, 2018) | |||
9-125153700-G-C | not specified | Uncertain significance (Dec 05, 2024) | ||
9-125158346-T-C | not specified | Uncertain significance (May 30, 2024) | ||
9-125160897-G-C | not specified | Uncertain significance (Dec 28, 2022) | ||
9-125189564-G-A | not specified | Likely benign (Aug 12, 2024) | ||
9-125189577-G-A | not specified | Uncertain significance (Dec 05, 2022) | ||
9-125189579-G-A | not specified | Uncertain significance (Jun 02, 2023) | ||
9-125189597-G-C | not specified | Uncertain significance (Apr 23, 2024) | ||
9-125189693-T-C | not specified | Uncertain significance (Feb 10, 2022) | ||
9-125189698-G-C | not specified | Uncertain significance (Jun 21, 2021) | ||
9-125189704-G-T | not specified | Uncertain significance (Dec 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PPP6C | protein_coding | protein_coding | ENST00000451402 | 8 | 43367 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.855 | 0.145 | 125558 | 1 | 184 | 125743 | 0.000736 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.58 | 93 | 194 | 0.479 | 0.0000101 | 2218 |
Missense in Polyphen | 24 | 78.479 | 0.30582 | 945 | ||
Synonymous | -0.568 | 75 | 69.0 | 1.09 | 0.00000346 | 665 |
Loss of Function | 3.47 | 3 | 19.5 | 0.154 | 0.00000106 | 224 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000663 | 0.0000663 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00815 | 0.00731 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000853 | 0.0000791 |
Middle Eastern | 0.00815 | 0.00731 |
South Asian | 0.00133 | 0.00127 |
Other | 0.000170 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalytic subunit of protein phosphatase 6 (PP6). PP6 is a component of a signaling pathway regulating cell cycle progression in response to IL2 receptor stimulation. N-terminal domain restricts G1 to S phase progression in cancer cells, in part through control of cyclin D1. Downregulates MAP3K7 kinase activation of the IL1 signaling pathway by dephosphorylation of MAP3K7. Participates also in the innate immune defense against viruses by desphosphorylating RIG-I/DDX58, an essential step that triggers RIG-I/DDX58-mediated signaling activation. {ECO:0000269|PubMed:10227379, ECO:0000269|PubMed:17079228, ECO:0000269|PubMed:17568194, ECO:0000269|PubMed:29053956, ECO:0000269|PubMed:9013334}.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;IL1;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;TNFalpha;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport
(Consensus)
Recessive Scores
- pRec
- 0.338
Intolerance Scores
- loftool
- 0.272
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.75
Haploinsufficiency Scores
- pHI
- 0.570
- hipred
- Y
- hipred_score
- 0.714
- ghis
- 0.608
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.584
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ppp6c
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; immune system phenotype;
Gene ontology
- Biological process
- G1/S transition of mitotic cell cycle;protein dephosphorylation;innate immune response;COPII vesicle coating
- Cellular component
- Golgi membrane;mitochondrion;cytosol
- Molecular function
- protein serine/threonine phosphatase activity;protein binding;metal ion binding